PB2010: FIRST-LINE TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES: A GLOBAL, RETROSPECTIVE OBSERVATIONAL COHORT STUDY
Amer M. Zeidan,
Aleksandra Butrym,
Aylin Yucel,
Gaurav Deshpande,
Min Che,
Tao Gu,
Hong Xiao,
Dimana Miteva,
Jose Alberto Nadal,
T. Kim Le,
Argiris Symeonidis
Affiliations
Amer M. Zeidan
1 Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT, United States
Aleksandra Butrym
2 Department of Cancer Prevention and Therapy, Wroclaw Medical University, Wroclaw, Poland
Aylin Yucel
3 Bristol Myers Squibb, Princeton, NJ, United States
Gaurav Deshpande
3 Bristol Myers Squibb, Princeton, NJ, United States
Min Che
3 Bristol Myers Squibb, Princeton, NJ, United States
Tao Gu
3 Bristol Myers Squibb, Princeton, NJ, United States
Hong Xiao
3 Bristol Myers Squibb, Princeton, NJ, United States
Dimana Miteva
3 Bristol Myers Squibb, Princeton, NJ, United States
Jose Alberto Nadal
3 Bristol Myers Squibb, Princeton, NJ, United States
T. Kim Le
3 Bristol Myers Squibb, Princeton, NJ, United States
Argiris Symeonidis
4 University of Patras Medical School, Hematology Division, Patras, Greece
